Poster Session 2
Category: Infectious Diseases
Poster Session 2
Noah w. Parker
Ungraduate Research Volunteer
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Jessian L. Munoz, MD, PhD
Perinatal Surgery Fellow
Texas Children's Hospital
Texas Children's Hospital, Texas, United States
Myla C. Stanford, BS
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Alexandra L. Hammerquist, MD
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Michael D. Jochum, Jr., PhD
Assistant Professor
Baylor College of Medicine
Houston, Texas, United States
Brian A. Burnett, MD
Baylor College of Medicine
Houston, Texas, United States
Emma Kelling
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Daniel Arnaud Dominguez, MD
Research Coordinator III
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Luis E. Delgadillo Chabolla, MD
Research Coordinator III
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Ahmed A. Nassr, MD, PhD
Associate Professor
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Roopali V. Donepudi, MD
Associate Professor
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Lori Showalter, MSc
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Cynthia Shope, MSc
Lab Manager
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Magdalena Sanz Cortes, MD, PhD (she/her/hers)
Associate Professor
Baylor College of Medicine
Baylor College of Medicine, Texas, United States
Enrico R. Barrozo, PhD
Assistant Professor
Baylor College of Medicine and Texas Children's Hospital
Houston, Texas, United States
Cytomegalovirus (CMV) is the leading cause of congenital infections, yet the timeline and specificity of fetal adaptive immune responses remain undefined. Prior studies have detected fetal T cell activation in CMV as early as 22 weeks, but lacked patient-level evidence of antigen-specific memory at early gestation. We hypothesized that clonal, CMV-specific fetal T cell memory responses can emerge before 22 weeks gestation and sought to test this by leveraging high-resolution single-cell analyses.
Study Design:
We collected fetal specimens from intrauterine transfusions (IUT; n = 3) and neural tube defect repair (NTD; n = 12) surgeries and used a single-cell multi-omics approach to compare 2 transplacental CMV infections with 12 cases lacking exposure histories. Downstream analyses were conducted with Seurat, clusterProfiler, and scRepertoire for T cell receptor (TCR) profiling.
Results:
Corroborating serological and histopathological clinical diagnoses, CMV gene expression was detected in 26 cells from the two CMV-infected patients, with 52% from monocyte lineages (Fig. 1a). Comparing CMV+ and CMV− cells from 166,107 single-cell transcriptomes to a reference of 1,075,352 cells (CZI CellxGene) identified 2,535 differentially expressed genes (DEGs; log2FC >1.4, FDR < 0.05). Pathway analysis revealed 720 significant GO enrichment pathways, highlighted by hundreds of genes in innate, myeloid, and leukocyte pathways (Fig. 1b-c; FDR < 0.05). A focused set of 16,515 cells with paired VDJ sequences revealed 12 unique clusters, including distinct CD8⁺ T cell populations (Fig. 2a). TCR mapping detected clonotypes matching known CMV-specific epitopes (UL29, pp65, IE1; Fig. 2b) and CMV-specific clonal expansion. Gene expression analysis of CMV-specific clonotypes showed limited Th1 responses.
Conclusion:
These findings set a new benchmark for fetal immune memory, revealing antigen-specific T cell competence at least three weeks earlier than previously recognized and informing earlier intervention strategies for congenital infections.